LABORATOIRES DERMATOLOGIQUES D'URIAGE : revenue, balance sheet and financial ratios

LABORATOIRES DERMATOLOGIQUES D'URIAGE is a French company founded 40 years ago, specialized in the sector Fabrication de parfums et de produits pour la toilette. Based in NEUILLY-SUR-SEINE (92200), this company of category ETI shows in 2024 a revenue of 204.8 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - LABORATOIRES DERMATOLOGIQUES D'URIAGE (SIREN 333502680)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue 204 842 815 € 178 554 557 € 155 572 371 € 140 365 704 € 124 967 634 € 125 779 720 € 111 942 060 € 107 432 460 € 101 748 309 €
Net income 5 110 224 € 7 631 977 € 11 061 273 € 13 436 830 € 9 481 394 € 8 868 119 € 8 867 132 € 8 425 382 € 6 755 959 €
EBITDA 19 454 913 € 20 052 721 € 22 678 169 € 25 861 860 € 20 823 272 € 20 308 258 € 15 719 563 € 18 631 539 € 14 996 564 €
Net margin 2.5% 4.3% 7.1% 9.6% 7.6% 7.1% 7.9% 7.8% 6.6%

Revenue and income statement

In 2024, LABORATOIRES DERMATOLOGIQUES D'URIAGE achieves revenue of 204.8 M€. Over the period 2016-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +9.1%. Vs 2023, growth of +15% (178.6 M€ -> 204.8 M€). After deducting consumption (55.6 M€), gross margin stands at 149.3 M€, i.e. a rate of 73%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 19.5 M€, representing 9.5% of revenue. This level of operating margin is satisfactory for the sector. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 5.1 M€, i.e. 2.5% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2024) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

204 842 815 €

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

149 273 359 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

19 454 913 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

9 729 749 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

5 110 224 €

EBITDA margin (2024) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

9.5%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 44%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Cash flow represents 3.4% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.005%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

43.893%

Cash flow / Revenue (2024) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

3.375%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

0.0

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

48.5%

Solvency indicators evolution
LABORATOIRES DERMATOLOGIQUES D'URIAGE

Sector positioning

Debt ratio
0.01 2024
2022
2023
2024
Q1: 0.02
Med: 16.22
Q3: 72.0
Excellent -9 pts over 3 years

In 2024, the debt ratio of LABORATOIRES DERMATOLOGIQ... (0.01) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
43.89% 2024
2022
2023
2024
Q1: 13.03%
Med: 38.97%
Q3: 62.54%
Good -13 pts over 3 years

In 2024, the financial autonomy of LABORATOIRES DERMATOLOGIQ... (43.9%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
0.0 years 2024
2022
2023
2024
Q1: 0.0 years
Med: 0.0 years
Q3: 1.85 years
Excellent -30 pts over 3 years

In 2024, the repayment capacity of LABORATOIRES DERMATOLOGIQ... (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 150.87. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 4.7x. Financial charges are adequately covered by operations.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

150.869

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

4.746

Liquidity indicators evolution
LABORATOIRES DERMATOLOGIQUES D'URIAGE

Sector positioning

Liquidity ratio
150.87 2024
2022
2023
2024
Q1: 133.67
Med: 232.72
Q3: 398.8
Average -19 pts over 3 years

In 2024, the liquidity ratio of LABORATOIRES DERMATOLOGIQ... (150.87) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
4.75x 2024
2022
2023
2024
Q1: 0.0x
Med: 0.69x
Q3: 9.22x
Good -13 pts over 3 years

In 2024, the interest coverage of LABORATOIRES DERMATOLOGIQ... (4.8x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 81 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 67 days. The company must finance 14 days of gap between collections and payments. Inventory turnover is 79 days (= Average inventory / Cost of goods x 360). Overall, WCR represents 115 days of revenue, i.e. 65.2 M€ to permanently finance. Over 2016-2024, WCR increased by +130%, requiring additional financing.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

65 152 306 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

81 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

67 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

79 j

WCR in days of revenue (2024) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

115 j

WCR and payment terms evolution
LABORATOIRES DERMATOLOGIQUES D'URIAGE

Positioning of LABORATOIRES DERMATOLOGIQUES D'URIAGE in its sector

Comparison with sector Fabrication de parfums et de produits pour la toilette

Valuation estimate

Based on 74 transactions of similar company sales (all years), the value of LABORATOIRES DERMATOLOGIQUES D'URIAGE is estimated at 13 379 942 € (range 6 494 479€ - 33 708 280€). With an EBITDA of 19 454 913€, the sector multiple of 0.6x is applied. The price/revenue ratio is 0.11x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2024
74 tx
6494k€ 13379k€ 33708k€
13 379 942 € Range: 6 494 479€ - 33 708 280€
Section all-time Aggregated at NAF section level

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
19 454 913 € × 0.6x
Estimation 12 159 822 €
3 683 868€ - 28 040 928€
Revenue Multiple 30%
204 842 815 € × 0.11x
Estimation 22 500 804 €
14 683 689€ - 51 192 702€
Net Income Multiple 20%
5 110 224 € × 0.5x
Estimation 2 748 950 €
1 237 193€ - 21 650 030€
How is this estimate calculated?

This estimate is based on the analysis of 74 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Fabrication de parfums et de produits pour la toilette)

Compare LABORATOIRES DERMATOLOGIQUES D'URIAGE with other companies in the same sector:

Voir toutes les statistiques du secteur Fabrication de parfums et de produits pour la toilette

Frequently asked questions about LABORATOIRES DERMATOLOGIQUES D'URIAGE

What is the revenue of LABORATOIRES DERMATOLOGIQUES D'URIAGE ?

The revenue of LABORATOIRES DERMATOLOGIQUES D'URIAGE in 2024 is 204.8 M€.

Is LABORATOIRES DERMATOLOGIQUES D'URIAGE profitable?

Yes, LABORATOIRES DERMATOLOGIQUES D'URIAGE generated a net profit of 5.1 M€ in 2024.

Where is the headquarters of LABORATOIRES DERMATOLOGIQUES D'URIAGE ?

The headquarters of LABORATOIRES DERMATOLOGIQUES D'URIAGE is located in NEUILLY-SUR-SEINE (92200), in the department Hauts-de-Seine.

Where to find the tax return of LABORATOIRES DERMATOLOGIQUES D'URIAGE ?

The tax return of LABORATOIRES DERMATOLOGIQUES D'URIAGE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does LABORATOIRES DERMATOLOGIQUES D'URIAGE operate?

LABORATOIRES DERMATOLOGIQUES D'URIAGE operates in the sector Fabrication de parfums et de produits pour la toilette (NAF code 20.42Z). See the 'Sector positioning' section above to compare the company with its competitors.